RATIONALE: Exhaled breath NO (FeNO) is a biomarker of asthma, but blood NO response has not been standardized. We previously reported that PBMC of IgE+ allergic adults produce significantly more NO at 5 days of culture compared with IgE-adults. This study used a new method to detect the response earlier.
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Association of global trends of national tobacco smoking rates with prevalence of pediatric asthma and allergy Shumaila Khan, MD FACP 1 , and Rauno Joks, MD, FAAAAI 2 ; 1 SUNY Downstate medical center, Brooklyn, NY; Center for Allergy and Asthma research, Brooklyn, NY, 2 SUNY Downstate Medical Center, Dept of Medicine, Brooklyn, NY; Center for Allergy and Asthma Research, Brooklyn, NY. RATIONALE: As there is a global decline in tobacco smoke prevalence, the rates of allergic diseases are increasing. Interestingly, tobacco exposure increases T-regulatory activity in murine models, which may suppress allergic responses. We determined whether there is an association between change in national tobacco smoking prevalence and change in childhood asthma and allergy throughout the world. METHODS: We compared the prevalence of asthma, allergic rhinoconjunctivitis and eczema results from phase I and phase III of the ISAAC study in children ages 6-7 and 13-14 with concurrent WHO tobacco prevalence for each ISAAC nation (n5 55), with an average of 7.2-year interval between ISAAC phase study. Change in raw prevalence's were determined. Statistical analysis was done using the Spearman correlation coefficients. RESULTS: Tobacco rates between year1 (Phase I) and year2 (Phase III) were 2% (SD52.6) lower on average. There was a significant positive correlation between the change in tobacco rate and asthma prevalence in the 13-14-year group (p50.02) but not the 6-7-year group (p50.6).
There was a significant negative correlation between change tobacco rate and change in eczema 6-7-year group (p50.047) but not 13-14-year group (p50.41). There was no correlation between the change in tobacco rate with change in allergic rhino-conjunctivitis in either 6-7 or 13-14-year group (p50.23 and 0.62, respectively). CONCLUSIONS: While decrease in tobacco smoking may decrease airway asthma responses, it may also increase eczema, possibly due to decrease in tobacco-mediated immune suppression. Here we evaluated the influence of the gut microbiome on anaphylaxis to peanut in mice. Specifically, we retrospectively examined the relationship between the pre-sensitization composition of the gut microbiome and postsensitization reactivity when challenged with peanut. METHODS: CC027/GeniUnc X C57BL/6J F1 and F2 mice were sensitized with peanut and cholera toxin for 4 weeks and challenged with peanut the following week. Fecal pellets were collected before and after sensitization and sequenced using 16S rRNA. Mice were characterized as strongly reactive (n522) and non-reactive (n523). Phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) was used to predict each sample's gut metagenome from its 16S data. RESULTS: Using supervised learning, we identified 5 clusters of metagenomic ratios important for predicting non-reactive versus strongly reactive mice (AUC 5 0.85). Cox regression identified a significant association between the log-ratio of glutamyl-tRNA reductases (K02492) to dipeptide transport system permease proteins (K12369) and reaction severity hazard. Strongly reactive mice with a log-ratio of K02492 to K12369 in the top 50th percentile had a mean predicted reaction time of 13.90(11.14-16.66 ) minutes compared to mice in the bottom 50th percentile with mean predicted reaction time of 8.67(6.47-10.87) minutes. Further, a log-ratio of K02492 to K12369 in the top 50th percentile versus bottom 50th percentile (HR50.34, p50.025) is associated with a reduction in reaction severity hazard. CONCLUSIONS: Metagenomic log-ratios derived from gut microbiome data may be important for predicting anaphylaxis.
